“Osteoporosis and resultant fractures of the spine, hip and
other sites are important public health problems with significant individual
and societal costs. The risk for osteoporotic fracture is based upon low bone
density and the presence of one or more clinical risk factors (see Table 1). A
history of fracture during adulthood or falls are important clinical factors in
determining the risk of future fracture; however, age is the most influential
risk factor, such that middle-aged adults with other risk factors are likely to
be at low absolute fracture risk in the medium term. Using these clinical risk
factors and BMD when available, fracture risk assessment tools (based upon data
collected from large prospective observational studies) have been developed to
estimate the 5–10 year probability of hip fracture and other fractures in
untreated patients. Clinicians should be aware that fracture risk can also be
estimated using the FRAX or Garvan tools without BMD data. Chronic
glucocorticoid use is an established risk factor for osteoporosis, with studies
showing that use of glucocorticoids leads to accelerated bone loss and an
increased risk of fracture. Other drugs are increasingly recognized as
potential causes of bone loss and fracture, particularly amongst predisposed
individuals….”
See the following link for more on other drugs that can
cause bone loss and fractures:
Table
1. Clinical risk factors for fracture
|
Advancing age
|
Previous fracture during adulthood
|
History of a fall or falls in the
past 12 months
|
Glucocorticoid therapy
|
Parental history of hip fracture
|
Low body weight
|
Current cigarette smoking
|
Excessive alcohol consumption
|
Medical diseases (e.g. rheumatoid
arthritis, hyperparathyroidism, coeliac disease, hypogonadism)
|
This introduction and table
appeared in “Adverse Skeletal Effects of Drugs – Beyond Glucocorticoids,” Susannah O'Sullivan, Andrew Grey, Clin
Endocrinol. 2015; 82(1):12-22.
http://www.medscape.com/viewarticle/837369?src=wnl_edit_tpal&uac=127701PY
2 comments:
Have you seen this link? This Dr. is saying that strontium could actually increase risk of fracture. But that's the first time I have read that.
A lot of combat athletes are using it now as a preventative measure, and also I see most people who have done density scans always score much higher after supplementing with it.
http://saveourbones.com/strontium-demistyfied/
On the other hand that site seems to be selling a product so I'm not sure how much weight I am putting into its analysis, just wanted to see if you had an opinion on it as it focuses on "tensile strength" of the bone.
Derek,
I am well aware of Vivian Goldschmidt and her Save Our Bones program. She is NOT a doctor. She has a Masters of Arts degree in nutritional sciences and biochemistry. She sells supplements, books & videos.
My bone density while on strontium citrate went from osteoporosis to osteopenia as of my last scan almost two years ago. I may be in the normal range by now. Everyone I know who has taken strontium correctly & has no secondary cause of OP, such as hyperparathyroidism or malabsorption problems,has had increased BMD.
There are many scholarly articles showing that strontium decreases fracture risk:
Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia.
http://www.ncbi.nlm.nih.gov/pubmed/17997711
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
http://www.ncbi.nlm.nih.gov/pubmed/16598373
Strontium ranelate: a new paradigm in the treatment of osteoporosis.
http://www.ncbi.nlm.nih.gov/pubmed/12698204
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
http://www.ncbi.nlm.nih.gov/pubmed/18512789
Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
http://www.ncbi.nlm.nih.gov/pubmed/16735841
Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
http://www.ncbi.nlm.nih.gov/pubmed/16455319
Post a Comment